Advanced Search

Oncology & Hematology Coding Alert

You Be the Coder:

Append Modifier 53 for Discontinued Infusions

Published on Fri Apr 17, 2015

Question: Our physician treated a patient of non-Hodgkin’s lymphoma with rituximab. There is documentation for an adverse reaction within the first 15 minutes of the infusion. How can we report this drug administration? Can we submit a code for infusion or do we report this as a push? New York Subscriber Answer: Your physician intended to administer rituximab as an infusion, [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All